title: Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
abstract: A key mission of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association is to ensure a coherent view for management of hepatocellular carcinoma (HCC) and to advance new treatment for this difficult disease. At the 5th APPLE meeting, held in July 2014 in Taipei, Taiwan, an APPLE consensus development program was established to facilitate discussion among experts in the Asia-Pacific region on pertinent issues for HCC management, including (1) surgery for intermediate/advanced-stage disease, (2) prevention of HCC recurrence after curative treatment, (3) optimizing imaging diagnosis, (4) radiotherapy: current practice and future clinical trials, and (5) the role of cytotoxic chemotherapy. A pre-congress questionnaire was undertaken with the consensus development committee members to help understand the current practice patterns for HCC in the Asia-Pacific region and to identify issues relating to optimal patient care and further clinical trials for which consensus needs to be developed. In this report, the results of the questionnaire are presented, and the pertinent issues identified by each consensus group for further discussion and consensus development are summarized.
authors.affiliation: Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan ; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan (ROC).
authors.forename: Chiun
authors.initials: C
authors.lastname: Hsu
authors.affiliation: Department of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan.
authors.forename: Bang-Bin
authors.initials: BB
authors.lastname: Chen
authors.affiliation: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan.
authors.forename: Chien-Hung
authors.initials: CH
authors.lastname: Chen
authors.affiliation: Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan.
authors.forename: Ming-Chih
authors.initials: MC
authors.lastname: Ho
authors.affiliation: Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan ; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan (ROC).
authors.forename: Jason Chia-Hsien
authors.initials: JC
authors.lastname: Cheng
authors.affiliation: Department of Surgery, University of Tokyo Hospital, Tokyo.
authors.forename: Norihiro
authors.initials: N
authors.lastname: Kokudo
authors.affiliation: Department of Radiology, Kinki University Faculty of Medicine, Osaka, Japan.
authors.forename: Takamichi
authors.initials: T
authors.lastname: Murakami
authors.affiliation: Department of Clinical Oncology, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, SAR (China).
authors.forename: Winnie
authors.initials: W
authors.lastname: Yeo
authors.affiliation: Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea.
authors.forename: Jinsil
authors.initials: J
authors.lastname: Seong
authors.affiliation: Beijing Friendship Hospital, Capital Medical University, Beijing, China.
authors.forename: Ji-Dong
authors.initials: JD
authors.lastname: Jia
authors.affiliation: Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
authors.forename: Kwan-Hyub
authors.initials: KH
authors.lastname: Han
authors.affiliation: Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan ; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan (ROC), Japan ; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan (ROC).
authors.forename: Ann-Lii
authors.initials: AL
authors.lastname: Cheng
keywords: Chemotherapy; Hepatocellular carcinoma; Imaging; Radiotherapy; Surgery